Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 heures
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac tamponade, can strike. The company says patients recovering...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 12:12
Positive antibody persistence for vaccine treating mosquito disease
A single shot vaccine for mosquito-borne disease chikungunya has had positive antibody persistence data 12 months after vaccination. The primary endpoint also met with a 99% seroresponse rate. The...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34
The biggest private biotech investments in November 2022
The companies Emalex Biosciences, Osler Diagnostics and TauRx Pharmaceuticals bagged the biggest biotech investments in November 2022. Around the world, oncology and cell therapy players attracted the...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57
Creating designer immune cells at scale
To prevent testing on animals and create more precise ways of testing therapeutics, the pharmaceutical industry is turning to human immune cells. However, the availability of cells has been limited to...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12
Partnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been awarded a contract for the second phase of developing standardized oncology workflows for...
www.labiotech.eu
Une question a été posée - Hier à 10:02
1 activité(s)
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio
Tris Pharma, Inc announced today (December 2) that they have expanded their partnership allowing Pediatrix Therapeutics to receive exclusive rights to commercialize its entire FDA-approved ADHD...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Five apps powering the future of at-home HIV tests
The smartphone revolution is providing a promising tool to combat the human immunodeficiency virus (HIV) epidemic. We’ve listed five HIV test apps in development that could help people carry out...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
FDA clears SparingVision’s investigational new drug application to treat ocular diseases
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) for SPVN06. The genomic medicine company has had its...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA) today has been hailed ‘fantastic news’ by those in the microbiome field. The product is approved to...
www.labiotech.eu
Charger plus d'actualités